Rare emergence of delamanid resistance in multidrug-/rifampicin-resistant tuberculosis patients receiving delamanid-containing regimens: a prospective multicentric study in China

Abstract Background Delamanid (DLM) is a promising drug recommended for treatment of multidrug-/rifampicin-resistant tuberculosis (MDR/RR-TB). However, there are very little data about the emergence of drug resistance in patients with the use of DLM-containing regimens. The study aimed to monitor th...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Wei Shu, Qingshan Cai, Yuping Huang, Yuanhong Xu, Yuanyuan Shang, Ruixia Liang, Liang Yan, Lin Wang, Long Jin, Yi Pei, Zhongfeng Huang, Shanshan Li, Yufeng Wang, Mengqiu Gao, Liang Li, Yu Pang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2026-07-01
סדרה:	Annals of Clinical Microbiology and Antimicrobials
נושאים:	Tuberculosis Delamanid resistance Multidrug-/Rifampicin-resistant
גישה מקוונת:	https://doi.org/10.1186/s12941-025-00820-9
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!